Business Context and Reporting Period
This Form 8-K Current Report was filed by McKesson HBOC, Inc. on February 26, 2001. The filing addresses significant corporate governance changes and business unit restructuring effective April 1, 2001.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on organizational changes rather than financial performance data.
Material Changes
- Leadership Transition: John H. Hammergren, currently co-CEO and CEO of the McKesson HBOC business unit, will become the sole President and CEO of McKesson HBOC, Inc. effective April 1, 2001.
- Executive Departure: David Mahoney, currently co-CEO and CEO of the iMcKesson business unit, will resign from the Company and its Board of Directors.
- Business Restructuring: The iMcKesson business unit is being restructured. Physician offerings and the transaction hub will move to the Information Technology Business. The medical management business will become a standalone unit reported within the Supply Management Business.
Outlook, Risks, and Management Commentary
Management commentary is limited to the announcement of the leadership transition and the strategic realignment of business units. The filing does not contain specific financial guidance, risk factors, or contingencies beyond the operational changes described. The full text of the press release is included as Exhibit 99.1.
Investor Verification Checklist
- Confirm the exact effective date of John H. Hammergren's appointment as sole President and CEO (April 1, 2001).
- Verify the specific financial reporting structure for the new standalone medical management unit within the Supply Management Business.
- Review the full press release (Exhibit 99.1) for additional details on the rationale behind David Mahoney's departure and the restructuring of iMcKesson.